Synopsis : Experts are moving beyond GLP-1 receptor agonists in diabetes and obesity management to a broader focus on protecting vital organs and improving overall metabolic health
329,330 Compared with ACEIs and ARBs, targeting AGT theoretically offers a more comprehensive blockade of the RAAS, minimizing escape mechanisms while maintaining renal homeostasis and intact tubuloglomerular feedback, thereby enhancing both efficacy and safety
For those who qualify for GLP-1s elsewhere, Noom is here as a crucial companion to help with adherence to the medication while avoiding muscle loss while building healthy habits to produce better and more sustainable weight loss outcomes
Hepatic Several studies have reported elevated liver enzymes in people who received anesthetic or subanesthetic doses of ketamine
However, understanding your individual metabolic profile and genetic predispositions to GLP-1 response can help you and your provider determine whether dual therapy or optimized single-agent treatment aligns with your health goals and safety baseline
While they often improve with time, they can worsen with improper dosing or if the medication is taken without lifestyle adjustments. Regular follow-ups and lab work help ensure the medication is working effectively and safely
